Ceva will show its latest innovations and share expert knowledge in poultry vaccination, equipment and services during the 19th World Veterinary Poultry Association (WVPA) congress. The congress takes place on September 7th- 11th in Cape Town, South Africa with Ceva as a diamond sponsor.
The congress gathers more than a thousand poultry specialists from around the world and presents an excellent opportunity to build and develop profitable exchanges and relationships.
Ceva will share its latest innovations and expert knowledge in poultry vaccination, equipment and services: “The Ceva stand will provide practical and technical information to help poultry producers to improve their performance using new technology products such as Transmune, Vectormune ND and Egginject”, says the company.
One hot topic sure to be discussed at the congress is the subject of avian influenza (AI). The disease has proved to be a major threat for the global poultry industry, disrupting international trade and inducing heavy economical losses in infected flocks. Nevertheless, there is still a debate raging about the necessity of AI vaccination.
In that context, during the congress, Ceva will hold a symposium with leading global figures, including the USDA, to address the current AI situation and discuss the differing industry perspectives. The symposium will be entitled: “Avian Influenza – The value of vaccination in changing times”.
The company states: “Ceva’s vector vaccine Vectormune AI offers a new way to control this disease in vaccinating countries around the world.”
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (19) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.